# FDA Inspection 1088851 - Tatjana A. Pejcic, MD PhD - April 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/tatjana-a-pejcic-md-phd/b6be847a-0a3c-4f99-b42e-e092e3eb375e
Source feed: FDA_Inspections

> FDA Inspection 1088851 for Tatjana A. Pejcic, MD PhD on April 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1088851
- Company Name: Tatjana A. Pejcic, MD PhD
- Inspection Date: 2019-04-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/tatjana-a-pejcic-md-phd/e4a24d44-0dd0-4cb3-a055-1421ac7ccafc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
